• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,886.91 -416.72
( -0.54%)
Global Indices
Nasdaq
49,198.35 -53.37
(-0.11%)
Dow Jones
7,195.79 9.71
(0.14%)
Hang Seng
59,839.06 -698.30
(-1.15%)
Nikkei 225
10,331.11 -47.97
(-0.46%)
Forex
USD-INR
93.91 -0.14
(-0.15%)
EUR-INR
110.02 0.03
(0.03%)
GBP-INR
127.00 0.16
(0.13%)
JPY-INR
0.59 0.00
(-0.03%)

EQUITY - MARKET SCREENER

Rossari Biotech Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
543213
INE02A801020
204.1276569
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ROSSARI
23.27
2803.23
EPS(TTM)
Face Value()
Div & Yield %
21.75
2
0.1
 

mkventures capital ltd
Shilpa Medicare enters into development and supply agreement with NXI Therapeutics AG
Feb 13,2026
Shilpa Medicare (SML) has entered into a binding agreement with NXI Therapeutics AG based out of Basel, Switzerland for development, supply of a New Chemical Entity (NCE). Under the terms of the strategic collaboration, SML will support both development – including first-in-human clinical studies – as well as long-term commercial supply with GMP manufacturing.